Cellular Aspects of Thyroid Hormones

  • M. C. Sheppard
  • Jayne A. Franklyn

Abstract

There is considerable evidence that the biological actions of thyroid hormones within the cell are mediated by binding to specific iodothyronine receptors found in close association with nuclear chromatin (1). There is an excellent correlation between the binding of T3 analogues to nuclear receptors and their thyromimetic potency. A second line of evidence is the correlation between the sensitivity of tissues to thyroid hormone action and the concentration of nuclear receptor sites in that tissue. Tissues such as the anterior pituitary and liver which are highly responsive to thyroid hormones have large numbers of nuclear receptors for T3, but tissues such as the testis and spleen, which are unresponsive to thyroid hormones, have little or no demonstrable nuclear binding. There is a clear relationship between nuclear occupation and nuclear response; when nuclear sites are fully saturated the measured biological response is maximal. The rapidity with which certain mRNA sequences change in response to T3 occupation of the nuclear sites further supports the concept of a causal relationship between the two. The receptor has been characterised as a non-histone protein of molecular weight 50,000 and a sedimentation coefficient of 3.5S. The receptors are of high affinity (Ka 5 × 1010 1/mol) and are an integral component of a larger unit, the receptor-containing chromatin complex.

Keywords

Sedimentation Dexamethasone Glucocorticoid Acetyl Prolactin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Oppenheimer JH. Thyroid hormone action at the nuclear level. Annals of Internal Medicine 1985; 102: 374–384.Google Scholar
  2. 2.
    Kumara-Siri MH, Shapiro LE, Surks MI. Association of the T3 nuclear receptor with the nuclear matrix of cultured growth hormone producing rat pituitary tumour cells. Journal of Biological Chemistry 1986; 261: 2844–2852.Google Scholar
  3. 3.
    Shupnik MA, Ardisson LJ, Meskell MJ, Bornstein J, Ridgway EC. T3 regulation of thyrotropin subunit gene transcription is proportional to T3 nuclear receptor occupancy. Endocrinology 1986; 118: 367–371.CrossRefGoogle Scholar
  4. 4.
    Melmed S, Park J, Hershman JM. Triiodothyronine induces a transferable factor which suppresses TSH secretion in cultured mouse thyrotropic tumour cells. Biochemical Biophysical Research Communications 1981; 98: 1022–1028.CrossRefGoogle Scholar
  5. 5.
    Franklyn JA, Wood DF, Balfour NJ, et al. Effect of hypothyroidism and thyroid hormone replacement in vivo on pituitary cytoplasmic concentrations of thyrotropin (TSH) β and α-subunit mRNAs. Endocrinology 1987; 120: 2279–2290.CrossRefGoogle Scholar
  6. 6.
    Franklyn JA, Wood DF, Balfour NJ, Ramsden DB, Docherty K, Sheppard MC. Modulation by oestrogen of thyroid hormone effects on thyrotrophin gene expression. Journal of Endocrinology 1987; in press.Google Scholar
  7. 7.
    Casanova J, Copp RP, Janocko L, Samuels HH. 5’-flanking DNA of the rat growth hormone gene mediates regulated gene expression by thyroid hormone. Journal of Biological Chemistry 1985; 260: 11744–11748.Google Scholar
  8. 8.
    Gurr JA, Kourides IA. Regulation of the transfected human glycoprotein hormone alpha subunit gene promoter. Endocrinology 1986; 119: T30 (abstract).Google Scholar
  9. 9.
    Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. The c-erb-A gene encodes a thyroid hormone receptor. Nature 1986; 324: 641–646.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • M. C. Sheppard
    • 1
  • Jayne A. Franklyn
    • 1
  1. 1.Department of EndocrinologyQueen Elizabeth HospitalBirminghamEngland

Personalised recommendations